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ABBREVIATIONS 
 
ACh, acetylcholine; ADNFLE, autosomal dominant nocturnal frontal lobe epilepsy; AP, 
action potential; AP5, D(-)-2-amino-5-phosphono-pentanoic acid; CNQX, 6-cyano-7-
nitroquinoxaline-2,3-dione; CTRL, control transgenic mice not expressing β2-V287L; EGABA, 
reversal potential of GABAergic currents; Fr2, frontal area 2; GAD, glutamic acid 
decarboxylase; KCC2, K
+
/Cl
-
 cotransporter-2; nAChR, nicotinic acetylcholine receptor; 
NKCC1, Na
+
/K
+
/Cl
-
 cotransporter-1; PB, phosphate buffer; PBS, phosphate buffered saline; 
PFC, prefrontal cortex; RT, reticular thalamic nucleus; SS, somatosensory cortex; TH, 
thalamus; TTX, tetrodotoxin; tTA, tetracycline-controlled transcriptional activator; VB, 
ventrobasal thalamic complex; VLG, ventral lateral thalamic geniculate nucleus; Vrest, resting 
membrane potential; WT, wild type. 
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ABSTRACT 
The Na
+
/K
+
/Cl
-
 cotransporter-1 (NKCC1) and the K
+
/Cl
-
 cotransporter-2 (KCC2) set the 
transmembrane Cl
-
 gradient in the brain, and are implicated in epileptogenesis. We studied  
the postnatal distribution of NKCC1 and KCC2 in wild-type (WT) mice, and in a mouse 
model of sleep-related epilepsy, carrying the mutant β2-V287L subunit of the nicotinic 
acetylcholine receptor (nAChR). In WT neocortex, immunohistochemistry showed a wide 
distribution of NKCC1 in neurons and astrocytes. At birth, KCC2 was localized in neuronal 
somata, whereas at subsequent stages it was mainly found in the somatodendritic 
compartment. The cotransporters’ expression  was quantified by densitometry in the 
transgenic strain. KCC2 expression increased during the first postnatal weeks, while the 
NKCC1 amount remained stable, after birth. In mice expressing β2-V287L, the KCC2 
amount in layer V of prefrontal cortex (PFC) was lower than in the control littermates at 
postnatal day 8 (P8), with no concomitant change in NKCC1. Consistently, the GABAergic 
excitatory to inhibitory switch was delayed in PFC layer V of mice carrying β2-V287L. At 
P60, the amount of KCC2 was instead higher in mice bearing the transgene. Irrespective of 
genotype, NKCC1 and KCC2 were abundantly expressed in the neuropil of most thalamic 
nuclei since birth. However, KCC2 expression decreased by P60 in the reticular nucleus, and 
more so in mice expressing β2-V287L. Therefore, a complex regulatory interplay occurs 
between heteromeric nAChRs and KCC2 in postnatal forebrain. The pathogenetic effect of 
β2-V287L may depend on altered KCC2 amounts in PFC during synaptogenesis, as well as in 
mature thalamocortical circuits. 
 
 
Key words: ADNFLE; β2-V287L; GABAergic switch; KCC2; prefrontal cortex; reticular 
thalamic. 
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INTRODUCTION 
The Na
+
/K
+
/Cl
-
 cotransporter-1 (NKCC1) and the K
+
/Cl
-
 cotransporter-2 (KCC2) are major 
regulators of the intracellular Cl
-
 concentration ([Cl
-
]i; Kaila et al., 2014a). In developing 
brains, the comparatively large amount of NKCC1 in neurons and astrocytes causes a high 
[Cl
-
]i, which maintains the reversal potential of the GABAA receptor currents (EGABA) at 
depolarized values (Ben Ari et al., 2007). Under these conditions, GABA release produces 
depolarizing effects that modulate neuronal maturation and synaptogenesis (Ben Ari et al., 
2007; Cancedda et al., 2007). Around birth, KCC2 expression progressively increases. By 
lowering [Cl
-
]i,
 
KCC2 leads EGABA to the typical hyperpolarized values observed in the adult 
brain (Rivera et al., 1999; Kaila et al., 2014a). In murine neocortex, such ‘GABAergic switch’ 
occurs during the first two postnatal weeks. Being concomitant with the formation of 
GABAergic synapses (Takayama and Inoue, 2010), it is thought to regulate the postnatal 
maturation of neuronal circuits (Ge et al., 2006; Ben-Ari et al., 2007). 
of abundance and activity of NKCC1 and KCC2 is implicated in The balance 
epileptogenesis as well as in the compensatory responses observed in hyperexcitable networks 
(Khirug et al., 2010; Kaila et al., 2014b). In fact, genetic variants of these cotransporters are 
linked to human idiopathic epilepsy (Kahle et al., 2014; Puskarjov et al., 2014). Epilepsy, 
however, comprises a heterogeneous spectrum of disorders (Jensen, 2011). The role of 
NKCC1 and KCC2 has been extensively studied in parietal and temporal lobe epilepsy 
(Dzhala et al., 2005; Aronica et al., 2007; Pathak et al., 2007; Li et al., 2008; Zhu et al., 2008; 
Talos et al., 2012; Awad et al., 2016; Karlócai et al., 2016), but not in frontal epilepsy. The 
latter presents distinct pathophysiological features, particularly in relation to the sleep-waking 
cycle. In frontal lobe epilepsy, sleep favors focal seizures, but not the occurrence of secondary 
generalization. The opposite holds in the focal epilepsies originating in other cortical regions 
(Shouse and Quigg, 2008). 
To address these issues, we focused on Autosomal Dominant Nocturnal Frontal Lobe 
Epilepsy (ADNFLE), the mendelian form of hypermotor sleep-related epilepsy, which is 
characterized by focal hyperkinetic seizures mainly occurring during non-rapid-eye-
movement sleep (Tinuper et al., 2016). ADNFLE is frequently caused by point mutations on 
genes coding for α or β subunits of the neuronal nicotinic acetylcholine receptor (nAChR; 
Tinuper et al., 2016). In the mammalian neocortex, the most widespread heteromeric nAChR 
is α4β2, and the first ADNFLE mutations identified on these subunits were α4-S248F 
(Steinlein et al., 1995) and β2-V287L (De Fusco et al., 2000). In heterologous expression 
systems, ADNFLE mutations often increase the nAChR function, at least in the heterozygous 
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state, by augmenting its sensitivity to the agonists or causing other kinetic alterations 
(Becchetti et al., 2015). Previous studies on the first conditional murine model of ADNFLE, 
expressing β2-V287L in the brain under control of a tetracycline promoter, suggest that the 
transgene could exert its effects during synaptogenesis (Manfredi et al., 2009). Mice carrying 
β2-V287L develop spontaneous epileptiform seizures, mostly occurring during periods of 
increased delta electroencephalographic activity, which is typical of slow-wave sleep. 
However, for the epileptic phenotype to manifest, β2-V287L must be expressed throughout 
brain development, until the end of the second postnatal week (Manfredi et al., 2009). These 
 several nAChR subunits, including results agree with recent lines of evidence suggesting that
β2, display a peak of expression between the second and third postnatal weeks in neocortex 
and hippocampus (Mansvelder and Role, 2006; Molas and Dierssen, 2014). It has thus been 
regulate he underlying cellular suggested that nAChRs synaptogenesis, even though t
mechanisms are largely unknown (Molas and Dierssen, 2014). Nonetheless, the spontaneous 
nAChR activity affects the developmental GABAergic switch in neuronal cultures (Liu et al., 
2006). In fact, both β2-containing nAChRs (Lozada et al., 2012) and KCC2 (Li et al., 2007; 
Fiumelli et al., 2013; Puskarjov et al., 2014) are involved in maturation and remodeling of 
dendritic spines. Moreover, rats expressing another nAChR mutation linked to ADNFLE (i.e. 
α4-S284L) display an altered KCC2/NKCC1 messenger ratio (Yamada et al., 2013). Hence, 
we hypothesized that an early regulatory link might exist between β2-containing nAChRs and 
the Cl
-
 cotransporters, which could have long-term effects on neocortex circuits and 
excitability. 
The timing of NKCC1 and KCC2 appearance in neocortex and thalamus (TH) was 
previously studied in rats (Clayton et al., 1998; Yan et al., 2001; Wang et al., 2002; Barthó et 
al., 2004; Kovács et al., 2014), mice (Hübner et al., 2001; Stein et al., 2004; Takayama and 
Inoue, 2010; Markkanen et al., 2014), and humans (Hyde et al., 2011; Sedmak et al., 2016). 
However, no detailed analysis is available in mouse for associative cortices and TH nuclei, 
the most relevant regions for a sleep-related frontal epilepsy. To investigate the interplay 
between α4β2 nAChRs and the Cl-/cation cotransporters, we first determined the NKCC1 and 
KCC2 distribution in developing neocortex and TH of wild-type (WT) mice. Next, we studied 
if the amount of these cotransporters was altered in mice expressing β2-V287L. The 
morphological analysis was coupled with a patch-clamp study of EGABA time course in 
prefrontal cortex (PFC) layer V, which is the most susceptible to develop epileptiform activity 
(Telfeian and Connors, 1998). Our results show that altering the function of β2-containing 
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nAChRs affects KCC2 expression during postnatal development, and suggest that this 
mechanism may contribute to epileptogenesis. 
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EXPERIMENTAL PROCEDURES 
 
Animals 
Mice were kept in pathogen-free conditions, with a 12 h light-dark cycle, and free access to 
water and food. All procedures followed the Italian law (2014/26, implementing the 
2010/63/UE) and were approved by the local Ethical Committees and the Italian Ministry of 
Health. For the morphological analyses of WT mice, we used 33 FVB mice (Harlan) of either 
sex, at the following embryonic (E) or postnatal (P) days: E14-15 (n = 6), P0-2 (n = 8); P5 (n 
= 2); P7 (n = 4); P12-P14 (n=5); P19-21 (n = 3); P40-60 (n = 5). The transgenic strain we 
used was the S3 line of double transgenic FVB (tTA:Chrnb2V287L) mice, which express β2-
V287L under a tetracycline-controlled transcriptional activator (tTA). These mice were 
compared with their littermates not expressing β2-V287L, which were either WT or bearing 
TRE-Chrnb2V287L or PrnP-tTA genotypes (Manfredi et al., 2009). For clarity, mice 
expressing the transgene are hereafter denoted as β2-V287L, while the control littermates are 
denoted as controls (CTRL). The morphological analysis was carried out on 14 animals of 
either sex for each experimental group (CTRL and β2-V287L), at P8 (n = 6), P21 (n = 6), and 
P60 (n = 16). Patch-clamp recordings were carried out on 15 CTRL (all PrnP-tTA) and 9 β2-
V287L mice, whose age distribution is detailed in the Results. No morphological or 
electrophysiological difference was observed between sexes. 
 
Brain regions 
For immunohistochemistry and densitometric analyses, by PFC we refer to the entire 
secondary motor region (also known as M2, or Fr2) in the dorsomedial shoulder of prefrontal 
cortex. According to Franklin and Paxinos (2008), coronal prefrontal sections were cut 
between +2.58 and +1.14 mm from bregma. For somatosensory cortex (SS), we sampled the 
extended SS region between +1.98 and +0.02 mm from bregma. Thalamic sections for 
reticular (RT) and ventrobasal (VB) nuclei were prepared between -0,58 and -1,82 mm from 
bregma. For patch-clamp experiments, coronal PFC (Fr2) slices were cut between +2.68 mm 
and +2.10 mm from bregma. 
 
Chemicals and drugs 
Chemicals and drugs were purchased from Sigma-Aldrich, except for D(-)-2-amino-5-
phosphono-pentanoic acid (AP5), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), and 
tetrodotoxin (TTX), which were purchased from Tocris Bioscience (UK). Stock solutions of 
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gramicidin D (100 mg/ml) and CNQX (20 mM) were prepared in dimethylsulfoxide. Stock 
solutions of GABA, AP5, and TTX were prepared in distilled water, stored at -20°C, and 
diluted daily to the final concentration in our extracellular solution. 
 
Tissue preparation for immunohistochemistry 
Postnatal mice were anesthetized with isoflurane and intraperitoneal 4% chloral hydrate (4 
ml/100 g, for mice younger than P14; 2 ml/100 g, for older mice), and sacrificed by 
intracardiac perfusion as described (Aracri et al., 2013). Embryos at E14-E15 were quickly 
removed from the perfused pregnant mouse (aged P40), and their heads immersed in 4% 
paraformaldehyde in phosphate buffer (PB), for 24 h at 4°C. Next, brains were removed and 
stored for 5 to 10 days in the same fresh fixative. Both embryonic and postnatal (until P14) 
brains were embedded in 5% agarose. Serial coronal brain sections (50 m thick) were cut 
with a Leica VT1000S vibratome. 
 
Primary antibodies 
Anti-NKCC1: T4 monoclonal antibody, originated from human colonic crypt (T84 cell) 
NKCC1, against the carboxy-terminus M902 to S1212 (Developmental Studies Hybridoma 
Bank; 1:100). Anti-KCC2: polyclonal, made in rabbit, against the N-terminal His-tag fusion 
protein, corresponding to residues 932-1043 of rat KCC2 (Millipore; diluted 1:600). Anti-
VGAT (vesicular GABA transporter): polyclonal, made in rabbit against the synthetic peptide 
corresponding to the N-terminal 75-87 amino acids of the rat protein (Synaptic Systems; 
1:800). Anti-VGLUT1 (vesicular glutamate transporter type 1): polyclonal, made in rabbit 
against Strep-TagR-fusion proteins containing the amino acid residues 456–560 of the rat 
VGLUT1/BNPI (brain-specific Na1-dependent inorganic phosphate transporter; Synaptic 
Systems; 1:500). Anti-MAP2 (microtubule-associated protein 2): monoclonal, made in mouse 
against the rat brain MAP2 (1:1000). Anti-neurofilament H, non-phosphorylated: monoclonal, 
made in mouse, (SMI32; Sternberger Monoclonals; 1:1000). Anti-GAD67 (glutamic acid 
decarboxylase type 1/67kDa): polyclonal, made in goat against the human recombinant 
glutamic acid decarboxylase type 1, rhGAD1 (aa 2-97) derived from E. coli (R&D Systems; 
1:300).  
 
Immunoperoxydase histochemistry for light and electron microscopy 
The immunoreaction was carried out as reported (Aracri et al., 2010), except that a mild 
pretreatment with ethanol (10%, 25%, 10% in phosphate buffered saline, PBS) was applied to 
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increase the immunoreagent penetration. Reaction specificity was assessed by negative 
controls, e.g. omission of primary antiserum. In these cases, no specific staining was 
observed. Briefly, sections were examined on a Leica DMRB microscope, and images were 
acquired using a Leica DCF 480 camera coupled to a personal computer. To generate Table 
1, two independent observers assessed the cotransporter distribution in different brain regions. 
At least 3 mice were examined for each developmental stage. We analyzed at least 3-4 
sections for each cortical region (PFC, SS), and 5-6 sections representative of the whole 
rostro-caudal thalamic extension. Several images were acquired per section. For 
ultrastructural analysis, sections were osmicated and epoxy-embedded after completion of the 
immunoenzymatic procedure. After polymerization, small areas from cerebral cortex and TH 
were cut with a razor blade and glued to blank resin blocks for sectioning with a Reichert 
ultramicrotome. Ultrathin sections (50–70 nm) collected on Cu/Rh grids were counterstained 
with lead citrate, or left unstained, and examined with a Zeiss LEO912AB electron 
microscope. 
 
Immunofluorescence histochemistry 
Sections were permeabilized and blocked as described for immunoperoxydase histochemistry. 
They were next incubated for two nights in a mixture of one/two primary antibodies, after 
staining with NeuroTrace
TM
 (1:50, Molecular Probes) and/or before staining with Hoechst 
(Molecular Probes), as necessary for cytoarchitecture analysis and cell counting. For 
NeuroTrace
TM
 staining, sections were treated as previously described (Aracri et al., 2010). 
After washing the primary antibodies with PBS, sections were incubated in the following 
mixture of secondary fluorescent antibodies: indocarbocyanine (Cy)2 (Jackson; 1:200), or 
CF
TM
488A-conjugated donkey anti-rabbit IgG (Biotium; 1:200), Cy3-conjugated donkey anti-
mouse (1:200) or RedX-conjugated donkey anti-goat (Jackson; 1:200), for 75 min at room 
temperature. After rinsing, samples were mounted on coverslips (sometimes after nuclear 
staining with Hoechst) with PBS/glycerol (1:1 v/v) and inspected with a Leica TCS-NT laser 
scanning confocal microscope, to visualize double or triple fluorescent labeling. 
 
Colocalization and densitometric analysis 
All confocal micrographs were collected at 40X with a Leica SP2 laser scanning confocal 
microscope, and analyzed with ImageJ. Identical parameters were used to acquire images 
from cortical and TH areas, for the colocalization analysis of NKCC1 with VGAT or 
VGLUT1, as previously described (Aracri et al., 2013). In brief, nonoverlapping pictures 
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were acquired in at least two different sections for neocortex or TH, so that double 
immunolabeling was studied in 3 or 4 fields per region in each animal. For two-color 
colocalization analysis, tissues were excited at 488 and 568 nm. To avoid crosstalk, the 
fluorescent signals of Cy2 (green) and Cy3 (red) were detected sequentially. Colocalization of 
NKCC1 with either VGAT or VGLUT1 was determined by generating 2D cytofluorograms 
(Bolte and Cordeliéres, 2006) by Leica Confocal software, as shown in Figures 2E, F. 
Generation of a binary mask of image data allowed to select in each region certain intensity 
value pairs in the cytofluorograms, which were labeled as white signals in the original images, 
to represent merged antigen localization (Fig. 2C, D). For densitometric analysis, cortical 
layers and TH nuclei were identified with NeuroTrace
TM
 and/or nuclear counterstaining; at 
least three/four distinct images were acquired to sample the different areas. For each animal, 
the mean fluorescence intensity of each image was divided by the number of neurons therein 
(counted with ImageJ). The values thus obtained were averaged among animals before 
plotting. For the densitometric analysis of NKCC1, we selected fluorescent images with low 
background (as shown in Fig. 8). The degree of colocalization of KCC2 or NKCC1 with 
different neuronal markers was calculated by comparing the Manders’ coefficients, computed 
with the JACoP plug-in of ImageJ software (Bolte and Cordeliéres, 2006). 
 
Patch-clamp in brain slices 
Mice were sacrificed after deep isoflurane anesthesia, and brains extracted as reported (Aracri 
et al., 2013). Coronal sections (300 μm thick) were cut from Fr2 PFC. Experiments were 
performed at 33-34°. EGABA was measured with the perforated patch method. The 
extracellular solution contained (mM): 135 NaCl, 21 NaHCO3, 0.6 CaCl2, 3 KCl, 1.25 
NaH2PO4, 1.8 MgSO4, 10 D-glucose, aerated with 95% O2 and 5% CO2 (pH 7.4). Pipette 
contained (mM): 140 K-Gluconate, 5 KCl, 1 MgCl2, 2.5 BAPTA, 10 HEPES, pH 7.25 
(adjusted with KOH). Gramicidin (up to 20 µg/mL) was only added to the solution filling the 
pipette shank. Borosilicate (Science Products) micropipettes (2-3 MΩ) were prepared with a 
P-97 Micropipette Puller (Sutter). GABA was applied onto the cell soma, by pressure ejection 
through a micropipette connected to a Narishige IM-3 microinjector. The recording apparatus 
was as described (Aracri et al., 2017). The comparison of the action potential (AP) firing of 
pyramidal neurons in mice expressing or not β2-V287L was carried out in a separate set of 
experiments. The resting membrane potential (Vrest) was measured in open circuit mode soon 
after patch rupture. Spike-width was measured at half-amplitude between AP threshold and 
peak. After-hyperpolarization was calculated as the difference between the most negative 
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potential reached after repolarization and the AP threshold. Capacitance and series resistance 
(up to ~75%) were always compensated. EGABA was determined by applying five consecutive 
0.5 s voltage ramps from -80 mV to -20 mV (or -85 mV to -40 mV), in either presence or 
absence of GABA (100 µM). The background currents were subtracted from the currents 
obtained in the presence of GABA. Holding potential was -68 mV. Measurements were 
carried out in the presence of extracellular TTX (0.5 µM), to block voltage-gated Na
+
 
currents, AP5 (50 µM) and CNQX (10 µM), to block ionotropic glutamate receptors. No leak 
subtraction procedure was ever applied. No correction for junction potentials was applied to 
the reported values of membrane potential. Data were analysed with Clampfit 10.6 (Molecular 
Devices), and OriginPro 9.1 (OriginLab). 
 
Statistical analysis 
Data are given as mean values ± standard error of the mean. The number of experiments (n) is 
the number of tested mice. Comparisons between two independent populations were carried 
out with unpaired Student’s t-test, after testing for data normality (with a Kolmogorov-
Smirnov test), and variance homogeneity (with F-test). In case of unequal variances, the 
Welch’s correction was applied. All determinations carried out in cells from the same animal 
were averaged, to avoid bias from nested data (Aracri et al., 2017). In the figures, p values are 
indicated by * (0.01 < p ≤ 0.05) or ** (p ≤ 0.01). Unless otherwise indicated, detailed 
statistics are given in the figure legends.  
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RESULTS 
We first studied the overall pattern of postnatal expression of NKCC1 and KCC2 in WT mice, 
as no previous systematic study is available for mouse forebrain. Next, we investigated the 
effect of β2-V287L expression on the cotransporters’ amounts between the second and the 
third postnatal week  (i.e. the critical stages of synaptogenesis), and in adult mice. Because 
ADNFLE is a sleep-related epilepsy with frequent implication of the frontal regions, we focus 
our study on both PFC and TH, and use SS as the classical reference cortex. 
 
Distribution of NKCC1 in postnatal cortex and TH of WT mice 
Immunoperoxidase localization of NKCC1 is shown in Fig. 1 for neocortex and TH, at birth 
(P0-P1) and P19-P21 (i.e. after completion of synaptogenesis). For PFC and SS, 
representative images are respectively displayed in Fig. 1A, B (P0-P1), and Fig. 1C, D (P19-
P21). NKCC1 was widely distributed in neocortex since birth, with no clear differences 
among layers. As for TH, the NKCC1 immunoreactivity was stronger and more stable in the 
anterior and posterior TH nuclei (i.e. the specific nuclei). Examples at P0-P1 and P19-P21 are 
shown, respectively, in Fig. 1E and 1F. In general, immunoreactivity resulted  stable in the 
different nuclei up to adult stages. 
In agreement with previous findings, NKCC1 was generally found in both astrocytes 
(labeled for GFAP; data not shown)  and neurons (Hübner et al., 2001; Yan et al., 2001; 
Wang et al., 2002). In the neocortex, the marked radial pattern of labeling indicates intense 
expression in the apical dendrites of pyramidal neurons at both P19-P21 (Fig. 1C, D), and 
P60 (Fig. 1G), and fainter labeling in cell bodies (Fig. 1G). Such pattern was confirmed by 
confocal analysis, as indicated by the representative images for SS shown in Fig. 2A (P2) and 
Fig. 2B (P60). In TH, strong immunoreactivity was also observed in thin and thick fiber 
bundles (such as those of internal capsule; Fig. 1H). 
Ultrastructural analysis also revealed NKCC1+ synaptic boutons in adult neocortex 
and TH (an example is given in Fig. 1I). The neurochemical nature of these synaptic 
terminals was investigated by studying the colocalization of NKCC1 with either VGAT 
(which labels GABAergic terminals), or VGLUT1 (which labels the majority of glutamatergic 
terminals; Graziano et al., 2008). Representative images for the neocortex at P60 are shown in 
Fig. 2C (NKCC1/VGAT), and Fig. 2D (NKCC1/ VGLUT1). The degree of colocalization 
was estimated by generating the corresponding 2D cytofluorograms, as illustrated in Fig. 2E 
(NKCC1/VGAT), and 2F (NKCC1/VGLUT1). The colocalization puncta are indicated as 
white spots in Fig. 2C, D. In the mature neocortex, the overlap between NKCC1 and VGAT 
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was always weak. In particular, the calculated M2 Manders’ coefficient for Fig. 2C, E was 
0.088. A higher degree of colocalization was generally observed for NKCC1 and VGLUT1, 
particularly in adult PFC (Fig. 2D, F). The calculated M2 coefficient for Fig. 2D, F was 0.8, 
indicating that 80% of the VGLUT1+ synaptic terminals also displayed the NKCC1 signal. 
On the other hand, in TH nuclei, NKCC1+/VGAT + boutons were only transiently observed 
in the second postnatal week (data not shown). 
 
Distribution of KCC2 in developing cortex and TH of WT mice 
The KCC2 distribution at different postnatal stages is illustrated in Fig. 3. Clusters of a few 
KCC2 positive (+) neurons were observed at P0-P1 in PFC layer V, and more abundantly in 
SS, along with an intense immunoreactivity in the marginal zone (Fig. 3A, B). The overall 
KCC2 immunoreactivity was stronger at P19-P21 (Fig. 3C, D). In TH, conspicuous labeling 
at birth was detected throughout the neuropil, except for RT (Fig. 3E). The anterior TH group 
displayed the highest labeling, followed by the posterior group and by the medial/intralaminar 
group. Such a distribution pattern was preserved at P19-P21 (Fig. 3E, F), when RT was 
almost devoid of KCC2 in its central region, whereas the lateral and medial borders displayed 
a fair labeling (Fig. 3F). These results suggest that KCC2 is expressed in TH earlier than in 
the neocortex. This was confirmed by KCC2 immunofluorescence at E14-E15, which showed 
a faint KCC2 signal in frontal and parietal preplate isocortices (Fig. 4A, B), but a more 
conspicuous labeling in the ventral (especially the ventral lateral geniculate nucleus, VLG, 
Fig. 4D) and dorsal TH (Fig. 4C, D). 
Differently from NKCC1, KCC2 was only expressed in neurons and dendrites (Fig. 
3G-J), and its distribution became increasingly polarized during development. In the 
neocortex, KCC2 was mainly confined to the neuronal cell bodies, during the first postnatal 
week (Fig. 2A; 3A, B, G; 4E, G). At P19-P21 (Fig. 3C, D), the transporter was also found in 
the dendritic neuropil, and outlined the cell membranes, as can be better appreciated in Fig. 
3H, at a higher magnification. A similar pattern was observed in the mature cortex (Fig. 2B; 
4F, H). In TH, such distribution shift occurred before birth (Fig. 4C, D), and postnatal 
neurons showed maximal KCC2 expression in the neuropil (i.e. dendrites), even in the 
scarcely labeled RT (Fig. 3J; 4I). 
As for the neurochemical nature of KCC2+ neurons in neocortex, during the first 
postnatal week both pyramidal neurons and GABAergic GAD67+ neurons (Fig. 4E, G)  
showed cytoplasmic immunoreactive puncta, probably vesicles, which also spread to 
proximal dendrites. After P7, KCC2 mainly outlined the membrane of pyramidal neurons 
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(labeled with SMI32; Fig. 4F), whereas in GAD67+ structures (i.e. comprising neuronal cell 
bodies, processes and puncta), KCC2 was confined to the dendritic shafts (Fig. 4H). A 
different pattern was observed in TH. The GABAergic neurons, which were mainly 
concentrated in RT, generally showed a weak KCC2 expression. An exception was 
constituted by the dendrites of the GAD67+ cells located on the medial border of RT (Fig. 
4I). KCC2 was however intensely expressed by the dendritic neuropil of all TH neurons (Fig. 
3E, F, J; 4I). 
A semi-quantitative summary of the distribution of NKCC1 and KCC2 in PFC and 
TH, as obtained by immunohistochemistry at the relevant ages, is reported in Table 1. 
 
The β2-V287L nAChR subunit altered the timing of KCC2 expression. 
To define more rigorously the spatiotemporal distribution of KCC2 at the critical postnatal 
stages as well as the ratio between KCC2 and NKCC1, a densitometric analysis was 
performed on confocal sections from mice expressing the transgene (β2-V287L) and the 
control littermates (CTRL). Because the maturation of synaptic circuits is accompanied by an 
increase in nAChR subunit expression between the second and the third postnatal weeks 
(Molas and Dierssen, 2014), we compared P8, P21 and adult (P60) tissue. Sections were 
labeled for KCC2 and NeuroTrace
TM
, or Hoechst 33258. The intensity of KCC2 fluorescence 
was divided by the number of cells identified with either marker. 
Fig. 5 shows the results obtained in the neocortex at P8 (Fig. 5A-D), P21 (Fig. 5E-H) 
and P60 (Fig. 5I-L). The time course of KCC2 expression in the transgenic strain was 
consistent with the one observed in WT mice. For example, in CTRL, the densitometric 
values in PFC layer V increased by more than 60% between P8 (0.49 ± 0.014; n =3) and P60 
(0.81 ± 0.05; n = 8; p < 0.01 with unpaired t-test; DF = 9), confirming the progressive 
increase of KCC2 amount after birth (cf. Table 1). The main differences between β2-V287L 
and CTRL mice were observed in PFC layer V, where smaller amounts of KCC2 were 
observed at P8 in β2-V287L mice (Fig. 5C). Such difference disappeared by P21 (Fig. 5G), 
and the effect was reversed at P60, when KCC2 expression was significantly higher in β2-
V287L mice (Fig. 5K). In particular, in layer V, the ratio between the mean KCC2 
fluorescence per cell in CTRL and β2-V287L decreased from ~1.32 (P8) to ~0.83 (P60). At 
the same ages, no differences were found in the KCC2 amounts in SS (Fig. 5D, H, L). 
To test whether the higher KCC2 amount observed in the PFC of adult β2-V287L 
mice could be partly ascribed to changes in the GABAergic neuronal populations, we 
analyzed the colocalization of KCC2 with GAD67. In PFC layer V, at P60 we observed the 
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typical KCC2+ outlines around the cell bodies of pyramidal neurons (Fig. 4F), in WT (Fig. 
4H), CTRL (Fig. 6A-A’) and β2-V287L (Fig. 6B-B’). In GAD67+ neurons, KCC2 
expression was generally scarce (Fig. 4H, 6A-A’), although some colocalization was 
observed in β2-V287L (Fig. 6B-B’). Hence, the higher KCC2 amount observed in the PFC of 
adult β2-V287L mice could partly depend on a different expression in GABAergic neuronal 
subpopulation. To determine the contribution of GABAergic cells to the total KCC2 
increment we quantified the overall colocalization of KCC2 and GAD67 (i.e. comprising 
neuronal cell bodies, processes and puncta). The degree of overlap was defined by M1 and 
M2 Manders’ coefficients, and was not significantly different between CTRL and β2-V287L 
mice. At P60, in PFC layer V, M1 (the fraction of colocalization on the total KCC2+ signal) 
was 0.17139 ± 0.00565 in CTRL, and 0.17008 ± 0.00743 in β2-V287L (p = 0.895, with 
unpaired t-test; n = 3); M2 (the fraction of colocalization on the total GAD67+ signal) was 
0.36657 ± 0.00933 in CTRL, and 0.35333 ± 0.01154 in β2-V287L (p = 0.423, with unpaired 
t-test; n = 3). 
In TH, our densitometric analysis was focused on RT and on the main somatosensory 
relay nucleus VB. Once again, this analysis was consistent with the pattern observed in WT 
(Table 1). For example, in CTRL, the mean fluorescence intensity per cell in RT was 0.85 ± 
0.07, at P8 (n = 3), and 1.7 ± 0.04, at P60 (n = 3; p < 0.001, with unpaired t-test; DF = 4). 
Representative images at P60 are shown in Fig. 7A-B. In both nuclei, no significant 
differences were observed between genotypes at early postnatal stages (not shown). However, 
at P60, the average KCC2 amount decreased in RT by ~20% in β2-V287L mice, compared to 
CTRL (Fig. 7C). Because in RT the KCC2+ signal was always confined to the GAD67+ 
dendritic neuropil (Fig. 4I), no analysis of overlap by Manders’ coefficients was performed. 
 
β2-V287L did not change NKCC1 expression. 
Because [Cl
-
]i is regulated by both KCC2 and NKCC1, our densitometric analysis was 
extended to NKCC1, in PFC and TH, at P8 and P60 (Fig. 8), i.e. the regions and ages 
displaying altered KCC2 amounts in β2-V287L mice. To this purpose, we used the T4 
antibody against NKCC1, which was also employed for the analysis of developing WT 
forebrain (Fig. 1, 2). This antibody was previously used in rodent neocortex, hippocampus 
and brain stem (Yan et al., 2001; Marty et al., 2002; Ge et al., 2006; Liu and Wong-Riley, 
2012) and presents a very good specificity (Chen et al., 2005). Representative images are 
shown in Fig. 8A, C, E, G. In PFC, NKCC1 expression presented no significant genotype-
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dependent alteration at P8 (Fig. 8B) and P60 (Fig. 8D). Similar results were obtained in TH 
(Fig. 8F, H). 
 
β2-V287L delayed the GABAergic switch in PFC layer V. 
The immunofluorescence results show that the retarded expression of KCC2 in PFC layer V 
of β2-V287L mice was not accompanied by major changes of NKCC1. We thus hypothesized 
that a lower ratio between the amounts of KCC2 and NKCC1 could be associated with a 
delayed GABAergic switch. This was tested by measuring EGABA in pyramidal cells of PFC 
layer V, in brain slices from P8-P9 and adult mice (older than P40). Layer V is prominent in 
the premotor Fr2 PFC, and presents large pyramidal neurons that are well recognizable since 
early postnatal stages. The morphological and electrophysiological properties of these 
neurons were previously described in detail (Aracri et al., 2010, 2013, 2015). In brief, they 
display regular spiking with frequencies between 10 and 30 Hz and moderate adaptation, in 
the presence of depolarizing stimuli of 150 to 300 pA. The electrophysiological features of 
these cells are reported in Table 2, for a representative sample of P37-P50 mice bearing or 
not β2-V287L. No statistical difference was observed between CTRL and β2-V287L in Vrest, 
spike width, the ratio between the fourth and the first spike intervals, and after-
hyperpolarization (with unpaired t-test). Similar values were measured in the second postnatal 
week (data not shown). In such pyramidal cells, we measured EGABA with the perforated patch 
method, to avoid perturbing [Cl
-
]i. Representative GABAergic current traces obtained by 
applying voltage ramps from -85 to -40 mV (or -80 to -20 mV, at P8-P9) are displayed in Fig. 
9A, for the indicated experimental groups. During brain maturation, EGABA progressively 
hyperpolarized, shifting from -48.6 ± 2.03 mV at P8-P9 (15 cells were sampled from 5 mice), 
to -58 ± 1.7 mV in adult mice (31 cells, from 10 mice; p < 0.01, compared with the younger 
mice; unpaired t-test). A similar pattern was observed in adult β2-V287L, where EGABA was -
56 ± 2.5 mV (13 cells, from 5 mice; not statistically different from CTRL, with unpaired t-
test). However, at P8-P9, in β2-V287L mice EGABA was more depolarized than in the controls 
(-42 ± 1.65 mV; 11 cells from 4 mice; p < 0.05, compared with CTRL, with unpaired t-test). 
These data are summarized Fig. 9B. They show that, in PFC layer V, the time course of 
EGABA hyperpolarization was delayed in β2-V287L mice, in agreement with our 
immunofluorescence results. 
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DISCUSSION 
We have analyzed the distribution of NKCC1 and KCC2 in the murine neocortex and TH, at 
different developmental stages. The study was carried out on both WT and a transgenic 
murine model of ADNFLE. The main finding was that mice carrying the mutant nAChR 
subunit β2-V287L displayed a delayed surface expression of KCC2 (but not NKCC1) in PFC 
layer V, during the first postnatal weeks. This led to a transient decrease in the ratio between 
KCC2 and NKCC1, which was accompanied by a retarded GABAergic switch. Moreover, 
expression of β2-V287L was also correlated to changes in KCC2 expression in adult PFC and 
RT thalamic nucleus. 
 
Regional distribution of NKCC1 and KCC2 in postnatal neocortex 
Previous work in rodents revealed a complex timing and cellular distribution of NKCC1 
expression, in different brain regions. Nonetheless, our data agree with the frequent 
observation that the NKCC1 messenger and protein reach the highest amounts in the 
neocortex between P7 and P21  (Plotkin et al., 1997; Clayton et al., 1998; Yan et al., 2001; 
Wang et al., 2002; Dzhala et al., 2005). Whether these levels of expression are retained in the 
adult is more controversial, as results depend on species as well as on the used antibodies and 
probes (Plotkin et al., 1997; Clayton et al., 1998; Hübner et al., 2001; Yan et al., 2001; Wang 
et al., 2002; Dzhala et al., 2005). Our results in both WT and transgenic mice suggest that the 
surface amount of NKCC1 remains overall stable in the mature PFC.   
As for KCC2, at birth it was specifically localized in the marginal zone and 
infragranular layers. Its expression increased thereafter, and reached the adult distribution by 
the third postnatal week, in both WT and transgenic mice. This process paralleled the 
GABAergic switch, which in neocortex and hippocampus is delayed compared to the 
subcortical structures (Fiumelli and Woodin, 2007; Kovács et al., 2014).  Once again, our 
results broadly agree with previous results in mouse showing that KCC2 increases in 
postnatal stages, although regional exceptions are observed (Wang et al., 2002; Kovács et al., 
2014; Markkanen et al., 2014). They also agree with several non-systematic determinations in 
rat (Lacoh et al., 2013), and human tissue (Hyde et al., 2011). Moreover, we found KCC2 
expression to be more precocious in SS. Together with other observations on more specific 
markers (Hyde et al., 2011; Aracri et al., 2013), these results support the notion that PFC 
matures more slowly than other brain regions, which could make it more liable to develop 
pathologies related to network maturation, such as certain forms of epilepsy and 
schizophrenia (Hyde et al., 2011; Lacoh et al., 2013; Kaila et al., 2014a; Kovács et al., 2014). 
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Cotransporters’ distribution in thalamic nuclei 
Minor differences were observed in the postnatal amounts of NKCC1 at the tested stages, in 
both WT and transgenic mice. A more complex pattern was displayed by KCC2. In WT mice, 
KCC2 was found in VLG and RT as early as E14-E15, and conspicuous expression was 
observed at birth in all TH nuclei (Table 1). Its amount remained relatively stable thereafter, 
except in RT, where a transient KCC2 decrease was observed at the end of the first postnatal 
weeks, in both WT (Table 1) and transgenic mice (see text). Although no other systematic 
comparison of the KCC2 distribution in mouse TH is available, previous evidence also points 
to early KCC2 expression in TH nuclei (Hübner et al., 2001; Li et al., 2002; Wang et al., 
2002; Stein et al., 2004; Horn et al., 2010; Markkanen et al., 2014). This likely reflects the 
quicker time course of thalamic circuit wiring, which is complete by P14-P15 (Amadeo et al., 
2001). In fact, [Cl
-
]i is essentially stable by the second postnatal week in rat VB (Glykys et al., 
2009). More specifically, the so-called relay nuclei (comprising the anterior region), show a 
rapid maturation that reflects the early establishment of the connections implicated in sensory 
map topography (Lopez-Bendito et al., 2003). By contrast, the adult RT is characterized by a 
weaker KCC2 immunolabeling compared with the more caudal adjacent relay nuclei (Barthò 
et al., 2004). Our results show that such difference is not precocious, but is caused by a 
postnatal decrease of KCC2 in RT. Although little is known about the development of 
synaptic connections in RT (Amadeo et al., 2001; Nagaeva and Akhamadeev, 2006; Hou et 
al., 2016), we hypothesize that proper synaptogenesis here requires KCC2 amounts similar to 
those present in other TH nuclei. Subsequently, KCC2 would stabilize at lower levels in the 
adult RT, where EGABA is more depolarized than in relay cells (Ulrich and Huguenard, 1997; 
Barthò et al., 2004; Sun et al., 2013), and the reciprocal GABAergic connections lead to 
excitatory effects (Sun et al., 2012). 
 
Cellular distribution of NKCC1 and KCC2 in neocortex and thalamus 
In neocortex and TH, our confocal and ultrastructural analysis showed wide expression of 
NKCC1 in neurons, axons, synaptic terminals and astrocytes in agreement with previous 
results (Hübner et al., 2001; Yan et al., 2001; Wang et al., 2002). NKCC1 was mainly found 
in the apical dendrites of cortical pyramidal neurons and in myelinated fiber bundles in TH, 
suggesting that specific mechanisms of NKCC1 regulation operate in distinct neuronal 
compartments (Hübner et al., 2001; Yan et al., 2001). Moreover, electron and confocal 
microscopy revealed NKCC1 in synaptic terminals. In particular, NKCC1 was found in 
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glutamatergic (VGLUT1+) terminals, especially in adult PFC. In contrast, NKCC1 was rarely 
found in GABAergic (VGAT+) terminals, except in developing TH. The study of NKCC1 
expression and function in presynaptic terminals is still in its infancy. Physiological evidence 
indicates that presynaptic NKCC1 can stimulate (Bos et al., 2011) as well as inhibit (Shen et 
al., 2013) neurotransmitter release, making it difficult to provide a general interpretation of 
our results. In immature rat spinal cord, NKCC1 activity enhances transmitter release from 
afferent fibers by favoring a GABA-dependent presynaptic depolarization (Bos et al., 2011). 
We can hypothesize that a similar mechanism is operant in the developing TH, thus 
facilitating the usual depolarizing role of GABA in early stages. In contrast, NKCC1 has been 
found to inhibit glutamate release in photoreceptors (Shen et al., 2013), a mechanism worth 
further investigation in the PFC VGLUT1+ terminals. 
At variance with NKCC1, the cellular distribution of KCC2 was different in cortical 
and TH neurons. In neonatal neocortex, KCC2 was mainly localized in cell bodies of 
pyramidal and GABAergic neurons. During the first postnatal week, KCC2 shifted to cell 
membranes and dendrites, even though a significant amount of the transporter was retained on 
the surface of pyramidal neurons’ somata. This presumably reflects the high density of 
GABAergic synapses around pyramidal cell bodies. Such a pattern is broadly similar to the 
one observed in other species (Stein et al., 2004; Dzhala et al., 2005; Li et al., 2007; Hyde et 
al., 2011; Kovács et al., 2014). On the contrary, the KCC2 immunoreactivity of TH nuclei at 
birth was much closer to the adult’s; this is consistent with the concept that, in rodents, KCC2 
appears earlier in the TH anlage than in neocortex. The KCC2+ outlines observed around 
pyramidal cell bodies were absent or discontinuous in cortical and TH GABAergic cells, 
where KCC2 immunoreactivity was mainly confined to the dendrites. We attribute such 
difference to the relatively low average density of reciprocal GABAergic terminals among 
inhibitory interneurons in neocortex and TH (Pi et al., 2013; Hou et al., 2016; Aracri et al., 
2017). 
 
The effect of β2-V287L on cotransporters’ amounts and the GABAergic switch 
In rodent neocortex, the nAChR subunit expression peaks in the second postnatal week, and 
recent lines of evidence indicate that synaptic maturation is regulated by both α7- and β2-
containing nAChRs (Molas and Dierssen, 2014). Because the maximal nAChR expression is 
β2-V287Lconcomitant with the GABAergic switch, we studied if  affected the Cl- 
cotransporters. Between the first and the second postnatal week, the increase of KCC2 
expression was delayed by β2-V287L, in PFC layer V. Since the effect was not accompanied 
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by any alteration of NKCC1, we expected mice expressing   to also display a more β2-V287L
depolarized EGABA, around P8. In fact, the GABAergic switch was delayed in these animals. 
Our data suggest that a regulatory interaction occurs between KCC2 and heteromeric nAChRs 
during synaptogenesis. The specific effect observed in layer V is consistent with the fact that, 
in this layer, the action of ACh is dominated by β2-containing nAChRs (Aracri et al., 2013; 
β2-V287LPoorthuis et al., 2013). Previous work also showed that expression of  does not 
change the amount of heteromeric nAChRs on the plasma membrane (Manfredi et al., 2009). 
Therefore, we attribute the action of the mutant subunit to the functional alterations it 
produces on nAChRs, rather than to an overall alteration of nAChR expression. Both β2-
containing nAChRs (Lozada et al., 2012; Molas and Dierssen, 2014) and KCC2 (Li et al., 
2007; Fiumelli et al., 2013) regulate the formation and maturation of dendritic spines by 
mechanisms that are thought to involve the actin cytoskeleton. Because activating nAChRs 
leads to both membrane depolarization and Ca
2+
 influx, hyperfunctional mutant receptors 
β2-V287Lcontaining  (De Fusco et al., 2000) could alter KCC2 expression by interfering with 
calcium signals. An alternative explanation is based on the finding that β2-V287L, as well as 
other ADNFLE mutations, favors the assembly of the high-affinity (α4)2(β2)3 nAChR 
stoichiometry with respect to the low affinity (α4)3(β2)2 subtype (Son et al., 2009). One can 
hypothesize that the altered proportion of stoichiometric forms, besides altering the receptor’s 
response to the agonist, could modify the nAChR binding to some regulatory element of the 
dendritic spine machinery, or possibly to KCC2 itself. 
Irrespective of the molecular mechanism, the effect we observed around P8 was 
β2-V287Ltransient. At P60, the amount of KCC2 in PFC layer V was higher in  mice, even 
though EGABA was similar in adult mice carrying or not the transgene. Because layer V is 
highly susceptible to develop seizures (Telfeian and Connors, 1998), we hypothesize that the 
steady-state increase of KCC2 in the mutant is a compensatory mechanism. A higher local Cl
-
 
turnover would be necessary to sustain inhibition in an overactive network, and prevent a 
significant alteration of the steady state Cl
-
 levels. This explanation would be consistent with 
the observation that in chronic epileptic conditions (Pathak et al., 2007; Karlocai et al., 2016), 
or peritumoral tissue (Conti et al., 2011), the KCC2 amounts usually increase, which points to 
a long-term compensation of hyperexcitability. In fact, deleting KCC2 in mice facilitates 
epileptiform activity (Woo et al., 2002; Tornberg et al., 2005), and mutations impairing KCC2 
are linked to human epilepsy (Kahle et al., 2014; Puskarjov et al., 2014). It must be however 
recalled that the physiological meaning of the changes of KCC2 expression observed in 
epileptic networks is complex and still controversial, as the observed effects depend on the 
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pathophysiological context and the studied region. For example, in temporal lobe, acutely 
induced epileptiform activity (Rivera et al., 2002; Wake et al., 2007; Puskarjov et al., 2012), 
and the induction of status epilepticus (Pathak et al., 2007; Li et al., 2008; Barmashenko et al., 
2011) produce a chronic decrease of KCC2 surface expression, which is attributed to the 
action of higher calpain levels (Kaila et al., 2014b). 
β2-V287L As for the thalamic effects of mutant nAChRs, mice bearing  displayed a 
lower KCC2 level in the mature RT nucleus. Differently from the GABAergic cells in adult 
PFC, in which the somatic expression of nAChRs is population-specific (Aracri et al., 2017), 
the GABAergic RT neurons in mice express a relatively high density of postsynaptic α4β2 
nAChRs. These can effectively trigger action potentials, when the cholinergic afferents are 
hyperfunctional mutant nAChRs could over-stimulate activated (Sun et al., 2013). Therefore, 
RT neurons and boost calcium signaling therein. As discussed earlier, this could favor a 
calpain-dependent KCC2 downregulation. Such a mechanism could also be facilitated by the 
typical propensity of RT cells to enter into burst-like firing states (Fogerson and Huguenard, 
2016). 
In conclusion, the retardation of the GABAergic switch we observed in the PFC of 
mice carrying β2-V287L suggests that the pathogenetic mechanism in ADNFLE comprises 
physiological alterations during synaptogenesis that are likely to depend on the integrity of 
GABAergic signaling. In the adult, complex alterations of KCC2 expression were observed in 
the PFC and RT nucleus of mice expressing the transgene. Understanding the precise 
functional meaning of these alterations will require deeper studies on the thalamocortical 
excitability of these mice. Nonetheless, the fact that no such alteration was observed in SS 
cortex and the other TH nuclei is consistent with the hypothesis that the effect of β2-V287L is 
 specifically related to frontal hyperexcitability during sleep.
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Figure legends 
Fig. 1 Topographical and cellular distribution of NKCC1 in developing WT neocortex 
and thalamus (TH).  
Immunohistochemical localization of NKCC1 in PFC (A, C), SS (B, D) and TH (E, F) of P0-
P1 (A, B, E), and P19-P21 (C, D, F) mice. At both stages, NKCC1 was widely expressed in 
neocortex and TH, and mainly localized in the apical dendrites of PFC and SS pyramidal cells 
(arrowheads in A-D). Both in adulthood (G) and during development (H) NKCC1 was found 
in neurons of both neocortex and TH (arrows in G, H). NKCC1 staining was particularly 
intense in cortical apical dendrites (arrowheads in G), and in TH thin and thick axonal fibers, 
such as those of internal capsule (IC). Representative pre-embedding immunoelectron 
microscopy (TH at P60 in I)  showed NKCC1 in the axons of myelinated fibers (f), in some 
glial processes (g) and in few small synaptic terminals (t) contacting distal dendrites (d). CP, 
cortical plate; DLG, dorsal lateral geniculate thalamic nucleus; MZ, marginal zone; I-VI, 
cortical layers; VLG, ventral lateral thalamic geniculate nucleus; VPM, ventral posteromedial 
thalamic nucleus; VPL, ventral posterolateral thalamic nucleus. Scale bars: 150 µm (A-F); 50 
µm (G); 40 µm (H); 0.5 µm (I) . 
 
Fig. 2 Double immunofluorescence of NKCC1 with KCC2, or with synaptic markers, in 
WT neocortex. 
Representative images (A, B) combining the NKCC1 (red) and KCC2 (green) signals, in SS. 
(A) At P2, NKCC1 was found ubiquitously, especially in the neuropil; KCC2 only displayed 
punctate labeling in the somatodendritic compartment of a fraction of neurons (arrows). (B) 
At P60, KCC2 and NKCC1 were found in the apical dendrites, but their distribution scarcely 
overlapped. KCC2 was confined to the cell surface around neuronal cell bodies (asterisks in 
B) and proximal dendrites (arrowheads in B); in the same dendrites, NKCC1 showed a more 
diffuse, cytoplasmic distribution. (C) Colocalization of NKCC1 (red) and VGAT (green), in 
SS at P60. (D) Colocalization of NKCC1 (red) and VGLUT1 (green), in PFC at P60. (E, F) 
2D cytofluorograms showing the colocalization puncta in the region of interest (enclosed by 
the yellow ellipsoid) for NKCC1/VGAT (E) and NKCC1/VGLUT1 (F). These puncta are 
reported as yellow/white signals in the merged immunolabeling images (C, D), which 
represent high magnification details covering about one third of the entire fields acquired for 
colocalization analysis. At P60, very few terminals displayed both NKCC1 and VGAT signal 
colocalization (C), whereas the degree of colocalization between NKCC1 and VGLUT1 was 
much stronger (D). Scale bars: 20 µm. 
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Fig. 3 Topographical and cellular distribution of KCC2 in postnatal WT neocortex and 
thalamus (TH). 
Immunohistochemical localization of KCC2 in P0-P1 (A, B, E) and P19-P21 (C, D, F) mice. 
At birth, KCC2 was mainly confined to the neuronal cell bodies in PFC (A) and SS (B), and 
clusters of KCC2+ neurons were mainly found in layer V (arrows in A-B). At P19-P21, 
KCC2 was distributed throughout the neuropil in PFC (C) and SS (D). In TH nuclei, KCC2 
was already present at P0-P1 in the neuropil of all regions, except RT (E). At P21, KCC2 
expression in TH slightly decreased (F), and only a weak immunoreactivity was observed in 
the lateral and medial borders of RT (F). The immunoperoxidase localization of KCC2  
showed its presence only in the neuronal cells and dendrites (G-J). At P2 in PFC, KCC2 was 
localized in multipolar neurons (arrows in G). Subsequently, KCC2 became distributed in the 
neuropil and outlined cell membranes (arrows in H), as shown also by immunoelectron 
microscopical localization (I), where it was exclusively observed in cell bodies (CB) and 
proximal dendrites (D). In TH (J) KCC2 was mainly expressed by the dendritic neuropil, even 
in the scarcely labeled RT. N, nucleus; CP, cortical plate; DLG, dorsal lateral geniculate 
thalamic nucleus; MZ, marginal zone; I-VI, cortical layers; VLG, ventral lateral thalamic 
geniculate nucleus; VPL, ventral posterolateral thalamic nucleus; VPM, ventral posteromedial 
thalamic nucleus. Scale bars: 150 µm (A-F); 40 µm (G, H); 2 µm (I); 80 µm (J).  
 
Fig. 4 Localization of KCC2 in developing WT forebrain.  
A-D Topographical distribution of KCC2 in prenatal WT forebrain. Immunofluorescence 
staining for KCC2 (green) in embryonic (E14-E15) cortical (A, B) and thalamic (C, D) 
tissues; nuclei were stained with Hoechst (blue). KCC2 immunoreactivity was faint in frontal 
(FC) and parietal (PC) pre-plate isocortex (A, B), but strong in the rostral (C) and caudal (D) 
thalamic anlage. 
Double immunofluorescence in SS (E, G), PFC (F, H) and TH (I). Representative images are 
shown for KCC2 (green) and MAP2 (red) at P5 (E), KCC2 (green) and SMI32 (red) at P40 
(F), KCC2 (green) and GAD67 (red) at P0 and P40 (G-J). Around birth, KCC2 was mainly 
expressed in neuronal cell bodies in the neocortex (arrows in E, G). The MAP2+ pyramidal 
neurons and the GAD67+ interneurons showed cytoplasmic stained puncta, probably vesicles, 
spreading to proximal dendrites (E, G). In P40 neocortex, KCC2 was also found in dendrites 
(white arrowheads in F) and outlined (arrow in F) pyramidal cell membranes (asterisks in F, 
H), whereas only a small fraction of the GAD67+ dendritic shafts (yellow arrowheads in D) 
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also displayed KCC2 labeling. In TH (I), KCC2 was found in the dendritic neuropil of all TH 
neurons, and in the medial border of RT, where it displayed colocalization with GAD67 
(yellow arrowheads in I). MZ, marginal zone; CP, cortical plate; SP, subplate; DT, dorsal 
thalamus; TE thalamic eminence. Scale bars: 20 µm. Scale bars: 20 µm (A-D, H, I); 10 µm 
(E, G); 50 µm (F).  
 
Fig. 5 Effect of β2-V287L on KCC2 expression in neocortex during postnatal 
development.  
Immunofluorescence for KCC2 (green) counterstained with NeuroTrace
TM
 (red; NT) and 
Hoechst (blue), in PFC layer V of CTRL (A, E, I) and β2-V287L (B, F, J) mice, at the 
indicated ages. The corresponding densitometric analyses are summarized in the bar graphs 
for layers II/III and V from P8 (n = 3), P21 (n = 3) and P60 (n = 8) mice in PFC (respectively 
C, G, K), and SS (respectively D, H, L). Bars give average fluorescence intensity values 
divided by the number of neurons. At P8, KCC2 expression in PFC layer V (C) was 
significantly lower in β2-V287L (0.37 ± 0.004 vs 0.49 ± 0.014 in CTRL; p < 0.01, with t-test; 
n = 3) (C). The opposite was observed at P60, when KCC2 significantly increased in layer V 
of β2-V287L (0.98 ± 0.06, vs. 0.81 ± 0.05 in CTRL; p < 0.05, with t-test; n = 8) (K). No 
statistical difference between genotypes was observed in SS (with t-test). Scale bar: 20 µm. 
 
Fig. 6 Colocalization of KCC2 and GAD67 in PFC layer V of mice expressing or not β2-
V287L. 
Double immunofluorescence images in PFC layer V at P60, combining KCC2 (green) and 
GAD67 (red) localizations with nuclear staining with Hoechst (blue), for CTRL (A) and β2-
V287L (B). The corresponding single labeling for KCC2 is shown in (A’) for CTRL and (B’) 
for β2-V287L. Data represent the results obtained in 3 mice for each genotype. In CTRL, 
GAD67+ neurons showed a weak KCC2+ staining of somatic neuronal membranes (white 
arrowheads), but marked KCC2+ outlines of pyramidal neurons’ somata (yellow arrowheads). 
In β2-V287L, the KCC2 immunoreactivity pointed out somatic outlines also on some 
GAD67+ neurons (asterisks in B’). Scale bar: 20 µm. 
 
Fig. 7 Effect of β2-V287L on thalamic expression of KCC2 at P60.  
Representative immunofluorescence images for KCC2 (green) counterstained with Hoechst 
(blue), in TH nuclei of CTRL (A) and β2-V287L (B) mice. The corresponding densitometric 
analyses are shown in the bar graphs (C), for RT and VB nuclei, as indicated. Data are given 
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as mean fluorescence intensity values divided by the number of neurons. Mice bearing β2-
V287L displayed a decreased KCC2 amount in RT (1.38 ± 0.07, vs. 1.77 ± 0.04 in CTRL; p < 
0.01; DF = 4; unpaired two-sample t-test with equal variance assumed; n = 3). No significant 
difference was observed in VB (p = 0.777; DF = 4; unpaired two-sample t-test with equal 
variance assumed; n = 3). Scale bar: 20 µm. 
 
Fig. 8 Effect of β2-V287L on NKCC1 expression in developing PFC and TH. 
Representative images of immunofluorescence for NKCC1 (red) counterstained with Hoechst 
(blue), in PFC layer V (A, C) and TH nuclei (E, G) of CTRL and β2-V287L mice, at P8 (A, 
E) and at P60 (C, G). The corresponding densitometric analyses are summarized in the bar 
graphs for layers II-III and V from P8 and P60 mice in PFC (respectively B and D) and in 
thalamic nuclei RT and VB (F, H), at P8 (B, F) and P60 (D, H). Data are expressed as mean 
fluorescence intensity divided by the number of neurons. At P8 (n = 3) and P60 (n = 3), no 
significant differences were observed in NKCC1 expression between CTRL and β2-V287L, 
in either PFC or TH. For example, in RT at P60,  the mean fluorescence per cell was 0.73 ± 
0.046 in CTRL, and 1.1 ± 0.35 in β2-V287L (p = 0.396; DF = 2.07; unpaired t-test, assuming 
unequal variances). In VB, the corresponding values were 0.96 ± 0.1 (CTRL) and 1.13 ± 0.09 
(β2-V287; p = 0.27; DF = 4; unpaired t-test, assuming equal variances). Scale bar: 20 µm. 
 
Fig. 9 The effect of β2-V287L on the GABAergic switch.  
The time-course of EGABA was followed by perforated-patch experiments. Layer V pyramidal 
neurons were studied at P8-P9 or adult stages. (A) Representative current traces (averages of 
5 trials), elicited by voltage ramps (500 ms duration), in β2-V287L or CTRL mice, as 
indicated. The ramps between -85 and -40 mV are relative to adult mice. The ramp between -
80 and -20 mV is relative to a P8 mouse. The background current was always subtracted to 
the current measured in the presence of GABA. (B) Average EGABA values at the indicated 
stages, in CTRL and β2-V287L mice. Detailed statistics are given in the main text.  
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Table 1 
 
Developmental distribution of NKCC1 and KCC2 in the forebrain of WT mouse 
 
 E14-E15          P0-P2    P7      P19-P21          P40-P60 
 KCC2 NKCC1   KCC2 KCC2 NKCC1    KCC2      NKCC1    KCC2 
PFC +/-    +++        + ++    ++        +++                      ++     +++ 
SS +/-    +++       ++ ++    ++         ++        ++         ++ 
TH ant +    +++      +++ ++   +++        ++       +++        ++ 
TH me +/-     ++       +++ ++   +/++        +        ++          + 
TH VB +    +++      +++ +++   +++        ++       +++        ++ 
TH RT ++    +++       ++ +    ++        +/++        ++        +/++ 
TH LG +++    +++      +++  +++   +++       +++       +++       +++ 
 
 
Semi-quantitative analysis of the distribution of Cl
-
 transporters in different brain regions, at 
different ages, based on immunohistochemical localization, using anti-NKCC1 or anti-KCC2 
antibodies, as indicated. The comparison between neonatal and P40 stages for KCC2 was also 
carried out by densitometric analysis, with analogous results (not shown). PFC: prefrontal 
cortex; SS: somatosensory cortex; TH ant: anterior thalamic area; TH me: medial thalamus, 
i.e. intralaminar and midline nuclei; TH VB: thalamic ventrobasal complex; TH RT: reticular 
thalamic nucleus; TH LG:  lateral geniculate thalamic nuclei (comprising both dorsal and 
ventral lateral geniculate nuclei). 
-: negative; +/-: scarce; +: moderately positive; ++: positive; +++: markedly positive 
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Table 2. Expression of β2-V287L did not alter Vrest and the firing properties of 
pyramidal cells in PFC layer V. 
 
 
 
 
         Vrest   
        (mV) 
       Spike width 
             (ms) 
    4
th
spike interval/  
     1
st
spike interval 
       AHP 
        mV                           
           N 
 
CTRL  
 
   -69.4 ± 0.63       1.52 ± 0.08               1.8  ± 0.1                -9.3 ± 0.49           11 
β2-V287L    
 
   -68.9 ± 0.52       1.51 ± 0.05               1.9  ± 0.09              -9.3 ± 0.59             9 
 
  
   
Mice were aged P37-P50. The ratios between the fourth and the first spike interval were 
calculated in the presence of a 200 pA stimulation, and average firing frequency of ~15 Hz. 
No statistical difference was observed between mice expressing or not β2-V287L (with 
unpaired t-test). AHP: after-hyperpolarization. 
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HIGHLIGHTS 
 
NKCC1 and KCC2 were studied in mice bearing or not β2-V287L, an nAChR subunit linked 
to sleep-related epilepsy (ADNFLE). 
 
After birth, the KCC2/NKCC1 ratio increased in neocortex, and KCC2 was progressively 
found in the somatodendritic membranes. 
 
In PFC, KCC2 expression (and the GABAergic switch) was delayed by β2-V287L around P8, 
but reached higher amounts at P60. 
 
At birth, NKCC1 and KCC2 were abundant in thalamus. By P40, KCC2 declined in RT, and 
more so in mice bearing β2-V287L. 
 
The regulatory interplay between β2* AChRs and KCC2 in PFC and thalamus may contribute 
to the pathogenesis of ADNFLE. 
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